Evidence map›Paper›PMID 26399326›Full record

ArticleNature communications2015

HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling.

Rachel P J Lai, Graeme Meintjes, Katalin A Wilkinson, Christine M Graham, Suzaan Marais, Helen Van der Plas, Armin Deffur, Charlotte Schutz, Chloe Bloom, Indira Munagala and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 86 citations in OpenAlex.

  1. Trial
  2. Inflammasome-associated immune dysregulation in TB-HIV coinfection.Frontiers in cellular and infection microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Phenotypic Profile ofOpen forum infectious diseases · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Tuberculosis and Type 2 Diabetes Mellitus: An Inflammatory Danger Signal in the Time of Coronavirus Disease 2019.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  17. Review
  18. Review
  19. Review
  20. A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Rachel P J LaiThe Francis Crick Institute Mill Hill Laboratory, London NW7 1AA, UK.
Graeme MeintjesClinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Anzio Road, Observatory 7925, South Africa.
Katalin A WilkinsonThe Francis Crick Institute Mill Hill Laboratory, London NW7 1AA, UK.
Christine M GrahamThe Francis Crick Institute Mill Hill Laboratory, London NW7 1AA, UK.
Suzaan MaraisClinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Anzio Road, Observatory 7925, South Africa.
Helen Van der PlasClinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Anzio Road, Observatory 7925, South Africa.
Armin DeffurClinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Anzio Road, Observatory 7925, South Africa.
Charlotte SchutzClinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Anzio Road, Observatory 7925, South Africa.
Chloe BloomThe Francis Crick Institute Mill Hill Laboratory, London NW7 1AA, UK.
Indira MunagalaBaylor Institute for Immunology Research, Dallas, Texas 75204, USA.
Esperanza AnguianoBaylor Institute for Immunology Research, Dallas, Texas 75204, USA.
Rene GoliathClinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Anzio Road, Observatory 7925, South Africa.
Gary MaartensClinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Anzio Road, Observatory 7925, South Africa.
Jacques BanchereauBaylor Institute for Immunology Research, Dallas, Texas 75204, USA.
Damien ChaussabelSystems Immunology, Benaroya Research Institute, Seattle, Washington 98101, USA.
Anne O'GarraThe Francis Crick Institute Mill Hill Laboratory, London NW7 1AA, UK.
Robert J WilkinsonThe Francis Crick Institute Mill Hill Laboratory, London NW7 1AA, UK.
The Francis Crick Institute · GBUniversity of Cape Town · ZABaylor University · USWellcome Centre for Infectious Diseases Research in Africa · ZAImperial College London · GBBenaroya Research Institute

Funding

Medical Research Council MC_U117565642Medical Research Council U1175.02.002.00014.01Wellcome Trust 081667Wellcome Trust 097254Wellcome Trust 098316Wellcome Trust 104803
6 · The paper itself

Abstract

Patients with HIV-associated tuberculosis (TB) initiating antiretroviral therapy (ART) may develop immune reconstitution inflammatory syndrome (TB-IRIS). No biomarkers for TB-IRIS have been identified and the underlying mechanisms are unclear. Here we perform transcriptomic profiling of the blood samples of patients with HIV-associated TB. We identify differentially abundant transcripts as early as week 0.5 post ART initiation that predict downstream activation of proinflammatory cytokines in patients who progress to TB-IRIS. At the characteristic time of TB-IRIS onset (week 2), the signature is characterized by over-representation of innate immune mediators including TLR signalling and TREM-1 activation of the inflammasome. In keeping with the transcriptional data, concentrations of plasma cytokines and caspase-1/5 are elevated in TB-IRIS. Inhibition of MyD88 adaptor and group 1 caspases reduces secretion of cytokines including IL-1 in TB-IRIS patients. These data provide insight on the pathogenesis of TB-IRIS and may assist the development of specific therapies.

Indexed as

AdultAntiretroviral Therapy, Highly ActiveCaspase 1CaspasesCytokinesFemaleGene Expression ProfilingHIV InfectionsHumansImmune Reconstitution Inflammatory SyndromeImmunity, InnateInflammasomesInflammation MediatorsInterleukin-1Leukocytes, MononuclearMaleCASP5 protein, humanCaspase 1CaspasesCytokinesInflammasomesInflammation MediatorsInterleukin-1Membrane GlycoproteinsReceptors, ImmunologicReceptors, Interleukin-1TIRAP protein, humanToll-Like ReceptorsTREM1 protein, humanTriggering Receptor Expressed on Myeloid Cells-1

Identifiers

PMID26399326
PMCPMC4595995
OpenAlexW2395249890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.